Getting Biopharmaceutical Tech Transfer Right the First Time

May 15, 2017

BioPharm International

Volume 2017 eBook, Issue 1

Page Number: s27-s31

Good project management, budgeting, planning, and clear documentation are the only ways to prevent overruns and project failure.

Biopharmaceutical experts Stephen Perry, CEO of Kymanox, James Blackwell, principal consultant with The Windshire Group, and consultant Mike Ultee, share best practices and musts to avoid in biopharmaceutical technology transfer.  Some crucial takeaways?  Share all data (especially data on failed runs in the past), and include clear instructions for sampling.  In addition, aim for reproducibility.

 

Download BioPharm International's

.